document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center termination agreement style margin margin bottom text indent font size font family time roman small small small ermination small small greement small termination agreement entered into october nbsp between small akeda small small harmaceutical small small ompany small small imited small small small company organized under japan takeda having place business doshomachi chome chuo osaka japan small ntra small small ellular small small herapies small small small delaware corporation having place business audubon biomedical science technology park broadway york takeda referred herein individually party collectively party style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman small hereas small small small small small takeda party that certain license collaboration agreement dated february nbsp license agreement style margin margin bottom text indent font size font family time roman small hereas small small small party desire terminate license agreement entirety mutual written agreement accordance with term condition forth this termination agreement style margin margin bottom text indent font size font family time roman small hereas small small small party desire terminate certain agreement relating license agreement style margin margin bottom font size font family time roman align center agreement style margin margin bottom text indent font size font family time roman small small small herefore small small small consideration foregoing premise mutual covenant contained herein other good valuable consideration receipt sufficiency which hereby acknowledged party agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition table style margin margin bottom text indent font size font family time roman except forth herein capitalized term used otherwise defined this termination agreement shall have meaning ascribed such term license agreement style margin margin bottom text indent font size font family time roman transition completion date shall mean style margin margin bottom text indent font size font family time roman termination date shall date forth start this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination license agreement table style margin margin bottom text indent font size font family time roman termination termination date license agreement shall terminate entirety agreement between affiliate takeda affiliate relating license agreement including quality agreement between takeda takeda global research nbsp development center basf pharma evionnaz basf letter agreement between takeda basf style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman dated october nbsp memorandum understanding between takeda dated nbsp ancillary agreement shall terminate termination date provided that certain right obligation party under such agreement shall survive accordance with survival provision forth such agreement modified herein style margin margin bottom text indent font size font family time roman close activity party through oversight shall complete activity forth this termination agreement exhibit hereto accordance with written transition plan approved within termination date unless otherwise agreed party along with other such activity agreed upon party writing necessary complete activity forth this termination agreement exhibit hereto collectively close activity except forth herein shall appoint working group create such written transition plan work closely with party complete close activity transition working group notwithstanding anything contrary section nbsp license agreement should executive officer unable resolve dispute disagreement with respect scope close activity transition plan then such dispute shall referred neutral arbitrator reasonably acceptable both party resolution avoidance doubt subject diligence obligation forth this termination agreement each party shall have final decision making authority with respect performance close activity style margin margin bottom text indent font size font family time roman diligence each party will exercise level effort resource reasonably necessary perform respective obligation completion close activity with goal completing close activity later than transition completion date effort resource committed takeda complete close activity assigned prior transition completion date shall than level takeda would typically commit performance research program other compound currently under development avoidance doubt performance close activity other obligation hereunder takeda shall good faith shall take action that could reasonably expected have material adverse impact further development commercialization product event that despite applying foregoing level diligence takeda complete more close activity assigned prior transition completion date then takeda shall complete such activity quickly possible obligation takeda complete such activity shall survive transition completion date shall continue until such activity have been completed including avoidance doubt transfer information generated from such close activity event takada required complete such activity provided prior sentence then shall also facilitate completion such activity style margin margin bottom text indent font size font family time roman transition assistance part close activity takeda accordance with this section nbsp shall assist with cooperation reasonably necessary continue developing manufacturing commercializing product throughout territory notwithstanding other provision forth this section nbsp extent that contract between takeda third party assignable takeda shall reasonably cooperate assist with assist arrange receive service contemplated under such contract either from third party with whom takeda contracted style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman different third party provided however circumstance shall takeda required complete either directly indirectly through vendor activity beyond those activity forth this termination agreement exhibit termination date unless mutually agreed writing party avoidance doubt such assistance takeda shall include following style margin margin bottom text indent font size font family time roman material data information transfer unless otherwise prohibited applicable contract takeda will accordance with timing agreed upon party promptly return transfer assign designee agreed upon material including biological material sample information including without limitation case report form study database other study record regulatory material regulatory approval license third party agreement other item including without limitation drug master file inds ndas together with material correspondence with regulatory authority related compound product related data information relating product compound which shall deemed confidential information takeda provided that takeda will allowed retain available share future such material that regulatory authority requires takeda retain submit under applicable foregoing documentation data information that transferred english takeda will upon request translate foregoing into english deliver true accurate material respect translation thereof such information shall transferred designee organized clear manner with document file clearly labeled style margin margin bottom text indent font size font family time roman intellectual property transfer takeda hereby assigns effective termination date takeda entire right title interest each sole assigned patent half right title interest each joint assigned patent takeda appoints attorney fact solely make such reassignment authorizes make such assignment each case takeda shall execute deliver deed such assignment mutually agreeable form within termination date shall responsible recording such assignment takeda successor assigns shall nbsp reasonably cooperate with effort including satisfying assignment recording requirement relevant patent office nbsp reimburse reasonable documented pocket expense incurred connection with this section nbsp style margin margin bottom text indent font size font family time roman clinical study transfer style margin margin bottom text indent font size font family time roman toxicology study transfer upon completion close activity related toxicology study assigned under exhibit hereto takeda shall accordance with timing forth exhibit hereto otherwise agreed upon party transfer management continued performance week toxicology study product ongoing termination date shall promptly deliver agreed upon biological material information relevant such toxicology study designee style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman manufacturing process transfer pursuant section nbsp license agreement takeda shall transfer current manufacturing process designee instructed writing commencing upon termination date shall complete such transfer within month termination date provided however that failure timely complete such transfer matter outside takeda reasonable control shall deemed breach this termination agreement takeda takeda shall required provide cost expense more than exclusive travel time support transfer manufacturing process designee applicable event request takeda provide manufacture transfer support excess takeda shall enter into good faith negotiation consulting agreement pursuant which takeda would provide such continued support would reimburse takeda cost rate hour along with reasonable travel lodging expense notwithstanding section nbsp license agreement party agree that takeda need supply additional quantity product that returned product defined below sufficient requirement such that takeda shall required supply additional quantity clarity takeda obligation support transfer manufacturing process described herein shall survive transition completion date style margin margin bottom text indent font size font family time roman inventory transfer prior transition completion date takeda shall ship designee inventory compound product forth exhibit returned product party acknowledge that extent takeda required compound product complete close activity assigned that takeda required retain such compound product under applicable actual amount compound product delivered vary from amount forth exhibit party will agree term such shipment provided that shall have obligation reimburse otherwise compensate takeda cost manufacture such returned product this section nbsp supersedes section nbsp license agreement style margin margin bottom text indent font size font family time roman intellectual property license style margin margin bottom text indent font size font family time roman takeda hereby grant effective upon termination date exclusive fully paid worldwide fully transferrable irrevocable license with right grant sublicenses through multiple tier under style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman survival provision notwithstanding section nbsp license agreement party agree that following section within license agreement shall terminate upon termination date section development manufacturing activity nbsp foreign exchange payment method late payment record audit disclosure invention style margin margin bottom text indent font size font family time roman mutual release indemnification future activity style margin margin bottom text indent font size font family time roman consideration term forth this termination agreement behalf itself affiliate director officer stockholder employee such entity successor assigns foregoing releasors hereby style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman fully release takeda affiliate director officer employee such entity takeda releasees from claim action cause action liability damage judgment demand kind whether known unknown that releasors have ever claim have against takeda releasees under directly indirectly related license agreement except extent existing right obligation party under license agreement that survive provided section nbsp license agreement otherwise provided herein clarity foregoing provision shall release takeda releasees with respect nbsp takeda gross negligence violation nbsp claim third party extent that indemnification owed indemnitee accordance with article license agreement otherwise extent that claim third party caused arises from conduct takeda releasee style margin margin bottom text indent font size font family time roman consideration term forth this termination agreement takeda behalf itself affiliate director officer stockholder employee such entity successor assigns foregoing takeda releasors hereby fully release affiliate director officer employee such entity releasees from claim action cause action liability damage judgment demand kind whether known unknown that takeda releasors have ever claim have against releasees under directly indirectly related license agreement except extent existing right obligation party under license agreement that survive provided section nbsp license agreement otherwise provided herein clarity foregoing provision shall release releasees with respect nbsp gross negligence violation nbsp claim third party extent that indemnification owed takeda indemnitee accordance with article license agreement otherwise extent that claim third party caused arises from conduct releasee style margin margin bottom text indent font size font family time roman without limiting obligation either party under article license agreement under this agreement further agrees that shall defend indemnify hold takeda indemnitees harmless from against third party claim extent that such claim arises based result from manufacture handling storage sale other disposition compound back compound including variant thereof well product affiliate third party behalf after termination date foregoing indemnity obligation shall apply extent that takeda indemnitees fail comply with indemnification procedure forth section nbsp license agreement defense claim prejudiced such failure style margin margin bottom text indent font size font family time roman nothing this termination agreement shall deemed release acquit discharge either party affiliate agent representative employee officer director attorney successor assigns from obligation under this termination agreement claim arising from breach such obligation style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty table style margin margin bottom text indent font size font family time roman takeda takeda represents warrant that termination date style margin margin bottom text indent font size font family time roman takeda disclosed sole invention required under section nbsp license agreement style margin margin bottom text indent font size font family time roman takeda sublicensed assigned encumbered transferred technology style margin margin bottom text indent font size font family time roman takeda licensed assigned encumbered transferred assigned patent style margin margin bottom text indent font size font family time roman takeda kept informed major regulatory development relating compound product required section nbsp license agreement style margin margin bottom text indent font size font family time roman takeda terminated clinical trial product without prior written consent style margin margin bottom text indent font size font family time roman exhibit constitutes complete list takeda material activity related compound product ongoing date hereof style margin margin bottom text indent font size font family time roman represents warrant takeda that termination date sublicensed assigned encumbered transferred takeda technology style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign general table style margin margin bottom text indent font size font family time roman confidential information information furnished party affiliate other party affiliate pursuant this termination agreement shall confidential information defined subject provision article nbsp license agreement each party confidential information only permitted license agreement this termination agreement information received developed authored takeda respect product compound clinical trial other study conducted pursuant license agreement constitute confidential information subject going confidentiality disclosure obligation forth license agreement style margin margin bottom text indent font size font family time roman press release upon termination date party shall issue joint press release describing termination party collaboration under license agreement substantially form forth exhibit hereto style margin margin bottom text indent font size font family time roman dispute resolution article nbsp license agreement shall apply dispute matter arising under relating this termination agreement either party right obligation hereunder style margin margin bottom text indent font size font family time roman assignment neither party shall assign delegate right obligation under this termination agreement either whole part including assignment operation except with prior written consent other party except that party assign delegate right obligation under this termination agreement either whole part including assignment operation without prior written consent other party nbsp connection with transfer sale substantially business such party third party whether merger sale stock sale asset otherwise style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman including through assignment operation nbsp affiliate provided that assigning party shall remain liable responsible font style white space nowrap assigning font party hereto performance observance such duty obligation such affiliate party right obligation under this termination agreement will bind inure benefit their respective successor heir executor administrator permitted assigns except expressly permitted herein assignment this termination agreement shall null void style margin margin bottom text indent font size font family time roman notice notice which required permitted hereunder shall provided accordance with section nbsp license agreement style margin margin bottom text indent font size font family time roman applicable this termination agreement dispute arising related this agreement breach hereof shall governed construed under state york without giving effect choice principle that would require application different state party agree resolve dispute with respect this termination agreement accordance with article license agreement style margin margin bottom text indent font size font family time roman entire agreement amendment this termination agreement contains entire understanding party with respect subject matter hereof supersedes cancel previous express implied agreement understanding negotiation writing commitment either oral written respect subject matter hereof except provision section nbsp license agreement other provision license agreement referenced herein which shall survive accordance with their term this termination agreement amended term hereof modified only written instrument duly executed authorized representative both party hereto style margin margin bottom text indent font size font family time roman injunctive relief takeda acknowledges that failure perform close activity required herein cause irreparable harm which harm reasonably adequately compensated damage action reason thereof takeda agrees that shall entitled addition other remedy have under this agreement otherwise seek preliminary permanent injunctive other equitable relief prevent curtail actual threatened breach those section style margin margin bottom text indent font size font family time roman waiver rule construction each party opportunity consult with counsel connection with review drafting negotiation this termination agreement accordingly rule construction that ambiguity this termination agreement shall construed against drafting party shall apply style margin margin bottom text indent font size font family time roman english language this termination agreement english language english language shall control their interpretation addition notice required permitted given under this termination agreement written electronic oral other communication between party regarding this termination agreement shall english language style margin margin bottom text indent font size font family time roman counterpart this termination agreement executed number counterpart each which when executed shall deemed original which together shall constitute same document facsimile copy signature page signature delivered electronic mean shall effective original signature style margin margin bottom font size font family time roman align center remainder this page intentionally left blank style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman small small small itness small small hereof small small small party hereto have duly executed this small ermination small small greement small small small date forth above style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan small akeda small small harmaceutical small small ompany small small imited small valign bottom valign bottom valign bottom valign bottom colspan small ntra small small ellular small small herapies small small small style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman christophe weber valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman sharon mate style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign name valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman christophe weber valign bottom valign bottom valign bottom valign bottom name valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman sharon mate style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign title valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman president valign bottom valign bottom valign bottom valign bottom title valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman chief executive officer style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign date valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman october valign bottom valign bottom valign bottom valign bottom date valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman october table style margin margin bottom font size font family time roman align center small ignature small small small small small small ermination small small greement small style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center close activity style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid style margin margin bottom font size font family time roman align center functional style margin margin bottom font size font family time roman align center area valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center study valign bottom nbsp nbsp valign bottom align center style border bottom solid close activity valign bottom nbsp nbsp valign bottom align center style border bottom solid estimated completion date valign bottom nbsp nbsp valign bottom align center style border bottom solid party responsible style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center returned inventory style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid style margin margin bottom font size font family time roman activity valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center item valign bottom nbsp nbsp valign bottom align center style border bottom solid valign bottom nbsp nbsp valign bottom align center style border bottom solid quantity style font size height height colspan height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center form press release style margin margin bottom text indent font size font family time roman intra cellular therapy takeda announce mutual termination collaboration develop phosphodiesterase inhibitor disorder style margin margin bottom text indent font size font family time roman york date osaka japan date intra cellular therapy nasdaq itci takeda pharmaceutical company limited announced today that they have entered into agreement mutually terminate february license agreement covering intra cellular therapy proprietary compound related inhibitor return right these compound intra cellular therapy style margin margin bottom text indent font size font family time roman under term agreement intra cellular therapy regained worldwide development commercialization right compound previously licensed takeda takeda will responsible transitioning compound back intra cellular therapy will participate future development commercialization activity after transition program intra cellular therapy plan continue clinical development inhibitor treatment central nervous system cardiovascular other disorder style margin margin bottom text indent font size font family time roman grateful takeda substantial effort advancing this program into clinical development said nbsp sharon mate chairman intra cellular therapy this provides with opportunity unify platform look forward continuing development other inhibitor style margin margin bottom text indent font size font family time roman intra cellular therapy will discus program previously announced earnings call monday november nbsp participate conference call please dial nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp five minute prior start call participant passcode nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style margin margin bottom font size font family time roman about inhibitor style margin margin bottom text indent font size font family time roman inhibitor unique orally available investigational drug candidate being developed treatment cognitive impairment accompanying schizophrenia alzheimer disease other neuropsychiatric disorder neurological disease also treat patient with attention deficit hyperactivity disorder parkinson disease these compound also have potential improve motor dysfunction associated with these condition also have potential treat patient with multiple sclerosis other autoimmune disease pulmonary arterial hypertension these compound very selective subfamily relative other subfamily they have known significant target activity other enzyme receptor channel style margin margin bottom font size font family time roman about intra cellular therapy style margin margin bottom text indent font size font family time roman intra cellular therapy company developing novel drug treatment neuropsychiatric neurodegenerative disease other disorder central nervous system company developing lead drug candidate treatment schizophrenia behavioral disturbance dementia bipolar disorder other style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman neuropsychiatric neurological disorder company also utilizing phosphodiesterase platform other proprietary chemistry platform develop drug treatment disorder style margin margin bottom font size font family time roman forward looking statement style margin margin bottom text indent font size font family time roman this news release contains forward looking statement within meaning private security litigation reform that involve risk uncertainty that could cause actual result materially different from historical result from future result expressed implied such forward looking statement such forward looking statement include statement regarding among other thing proposed development plan portfolio inhibitor belief about potential benefit inhibitor research development effort plan under caption about intra cellular therapy such forward looking statement based management present expectation subject certain factor risk uncertainty that cause actual result outcome event timing performance differ materially from those expressed implied such statement these risk uncertainty include limited following current planned clinical trial other product candidate successful take longer more costly than anticipated product candidate that appeared promising earlier research clinical trial demonstrate safety efficacy larger scale later clinical trial reliance collaborative partner other third party development commercialization product candidate other risk factor discussed under heading risk factor contained annual report form year ended december nbsp filed with security exchange commission well update those risk factor filed from time time periodic current report statement contained this press release made only date this press release intend update this information unless required style margin margin bottom font size font family time roman about takeda pharmaceutical company limited style margin margin bottom font size font family time roman located osaka japan takeda research based global company with main focus pharmaceutical largest pharmaceutical company japan global leader industry takeda committed strive towards better health people worldwide through leading innovation medicine additional information about takeda available through corporate website takeda style margin margin bottom font size font family time roman takeda forward looking statement style margin margin bottom font size font family time roman this press release contains forward looking statement forward looking statement include statement regarding takeda plan outlook strategy result future other statement that description historical fact forward looking statement identified forward looking word such believe will expect project estimate should anticipate plan assume continue seek forma potential target forecast guidance outlook intend other similar word expression negative thereof forward looking statement based estimate assumption made management that believed reasonable though they inherently uncertain difficult predict investor cautioned unduly rely such forward looking statement style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman forward looking statement involve risk uncertainty that could cause actual result experience differ materially from that expressed implied forward looking statement some these risk uncertainty include limited nbsp economic circumstance surrounding takeda business including general economic condition japan worldwide nbsp competitive pressure development nbsp applicable regulation nbsp success failure product development program nbsp action regulatory authority timing thereof nbsp change exchange rate nbsp claim concern regarding safety efficacy marketed product product candidate development nbsp integration activity with acquired company style margin margin bottom font size font family time roman forward looking statement contained this press release speak only date this press release takeda undertakes obligation revise update forward looking statement reflect information future event circumstance after date forward looking statement takeda update correct more these statement investor others should conclude that takeda will make additional update correction style margin margin bottom font size font family time roman juan sanchez style margin margin bottom font size font family time roman vice president style margin margin bottom font size font family time roman corporate communication investor relation intra cellular therapy style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman burn mcclellan style margin margin bottom font size font family time roman lisa burn angeli kolhatkar investor style margin margin bottom font size font family time roman justin jackson medium style margin margin bottom font size font family time roman jjackson burnsmc style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman takeda pharmaceutical company limited style margin margin bottom font size font family time roman corporate communication dept style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center body html text document